RMC-4998 formic
Product Specifications
Target
PI3K, Apoptosis, ERK, mTOR, Ras
Related Pathways
MAPK, GPCR/G Protein, Apoptosis, PI3K/Akt/mTOR signaling
Bioactivity
RMC-4998 formic is an orally active inhibitor targeting the GTP-bound state of the KRASG12C mutant. It forms a trimeric complex with intracellular CYPA and the activated KRASG12C mutant, displaying an IC50 value of 28 nM. This compound inhibits ERK signaling and induces apoptosis in KRASG12C mutant cancer cells and is utilized in tumor research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP221269 200 Reactions
LOC285786 Human qPCR Primer Pair (XM_208349)
Sign In for Pricing
View Details 
